Typewriter Therapeutics: Funding, Investors & Team (Sep 2026)
Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
Typewriter Therapeutics has raised $56.0M across 1 funding round on record, the most recent a Series A of $56.0M announced in Sep 2026.
That round is above the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
Typewriter Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Typewriter Therapeutics Funding Rounds
Typewriter Therapeutics Investors
Typewriter Therapeutics Founders and Leadership Team
Contact details for the Typewriter Therapeutics team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Typewriter Therapeutics Funding in Context
Typewriter Therapeutics' latest round of $56.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Typewriter Therapeutics in Biopharma and Cambridge
Companies Similar to Typewriter Therapeutics
ClinicFlow is an AI voice agent that answers, schedules, and triages phone calls 24/7 for orthopedic, spine,…
Rubi.ai is an AI-powered deal engine for private markets, automating sourcing, screening, CRM, and…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Based in SF & NY we are building the technology stack to solve the experience, trust, and transparency…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
HiFi Bridge is a cryptocurrency payments platform that allows customers to buy and sell cryptocurrencies,…
Energy Domain is a platform that offers market analysis, an innovative auction system, and promotional…
AI + Open Source OS for MSPs
Steribite is a medical device company focused on developing unique, disposable products that improve patient…
Post ads, Find, Buy and Rent things.
FlexEtc offers flexible warehouse, office, and coworking spaces with all-inclusive pricing and terms for…
Typewriter Therapeutics Funding FAQs
What does Typewriter Therapeutics do?
Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes.
How much funding has Typewriter Therapeutics raised?
Typewriter Therapeutics has raised $56.0M across 1 round on record. The most recent is a Series A of $56.0M announced in Sep 2026.
When did Typewriter Therapeutics last raise funding?
Typewriter Therapeutics' most recent funding round on record is a Series A of $56.0M, announced in Sep 2026.
Who has invested in Typewriter Therapeutics?
Investors on record for Typewriter Therapeutics include RA Capital Management, ANRI, AN Ventures, Gemseki, SBI US Gateway Fund.
Who founded Typewriter Therapeutics?
FundedIQ lists Joe Neumeyer (Co-Founder) at Typewriter Therapeutics.
Who is the CEO of Typewriter Therapeutics?
Matthew Stanton is listed as Chief Executive Officer at Typewriter Therapeutics.
Where is Typewriter Therapeutics headquartered?
Typewriter Therapeutics is based in Cambridge, United States.
How many employees does Typewriter Therapeutics have?
Typewriter Therapeutics is in the 11-50 employee band.
When was Typewriter Therapeutics founded?
Typewriter Therapeutics was founded in 2022.
About FundedIQ's Typewriter Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Typewriter Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.